NCT05425472 2022-09-06A Phase II Study of HR070803 in the Treatment of Advanced Esophageal CancerJiangsu HengRui Medicine Co., Ltd.Phase 2 Unknown30 enrolled
NCT05174156 2022-07-14Study on the Biomarker of First-line Immunotherapy Combined With Chemotherapy in Advanced Esophageal CancerSixth Affiliated Hospital, Sun Yat-sen UniversityPhase 2 Unknown50 enrolled